Lung Cancer Clinical Trial

Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

Summary

This study has been designed to utilize already obtained biopsy specimens for investigation of the utility of a new, non-invasive optical diagnostic technique. The study will allow a careful correlation between the Optical coherence tomography findings and conventional histology.

View Full Description

Full Description

Optical coherence tomography is a non-invasive diagnostic technique that can provide information about tissue abnormalities, change in structure of an organ. This technique uses a near-infrared diode to emit light that can produce images of the specimen under investigation without causing damage or alterations.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult 18 years and older
Having procedure of endobronchial, transbronchial, and / or pleural biopsy

Exclusion Criteria:

Currently participating in any other investigational drug or device evaluation.
Currently taking drugs that are sensitive to light.

Study is for people with:

Lung Cancer

Study ID:

NCT00581503

Recruitment Status:

Withdrawn

Sponsor:

University of California, Irvine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Pulmonary and Critical Care Medicine, UCI Medical Center
Orange California, 92868, United States
Urology department, UCI Medical Center
Orange California, 92868, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Study ID:

NCT00581503

Recruitment Status:

Withdrawn

Sponsor:


University of California, Irvine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.